U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Eclipse GP III, LLC (0001763854)
State location: CA | State of Inc.: DE | Fiscal Year End: 1231
Business Address
514 HIGH STREET, SUITE 4
PALO ALTO CA 94301
(415) 692-1720
Mailing Address
514 HIGH STREET, SUITE 4
PALO ALTO CA 94301
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Rodgers Silicon Valley Acquisition Corp
Current Name:Enovix Corp
0001828318 2022-08-18 10 percent owner
Lucira Health, Inc. 0001652724 2021-02-04 10 percent owner


Items 1 - 19

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2022-08-18   Enovix Corp 4 J-Other --D 50000.0000 50000.0000 2 0001828318 Common Stock
D 2022-08-18   Enovix Corp 4 J-Other --D 50000.0000 0.0000 3 0001828318 Common Stock
D 2022-08-18   Enovix Corp 4 J-Other --I 5000000.0000 12583258.0000 1 0001828318 Common Stock
A 2021-02-09   Lucira Health, Inc. 4 C-Conversion --I 877445.0000 1854297.0000 2 0001652724 Common Stock
D 2021-02-09   Lucira Health, Inc. 4 C-Conversion --D 0.0000 10 0001652724 Convertible Promissory Note
D 2021-02-09   Lucira Health, Inc. 4 C-Conversion --D 3710257.0000 0.0000 9 0001652724 Series C Preferred Stock
D 2021-02-09   Lucira Health, Inc. 4 C-Conversion --I 185512.0000 0.0000 8 0001652724 Series C Preferred Stock
D 2021-02-09   Lucira Health, Inc. 4 C-Conversion --I 877445.0000 0.0000 7 0001652724 Series B Preferred Stock
D 2021-02-09   Lucira Health, Inc. 4 C-Conversion --I 976852.0000 0.0000 6 0001652724 Series A Preferred Stock
A 2021-02-09   Lucira Health, Inc. 4 C-Conversion --D 473729.0000 4183986.0000 5 0001652724 Common Stock
A 2021-02-09   Lucira Health, Inc. 4 C-Conversion --D 3710257.0000 3710257.0000 4 0001652724 Common Stock
A 2021-02-09   Lucira Health, Inc. 4 C-Conversion --I 185512.0000 2039809.0000 3 0001652724 Common Stock
A 2021-02-09   Lucira Health, Inc. 4 C-Conversion --I 976852.0000 976852.0000 1 0001652724 Common Stock
- -   Lucira Health, Inc. 3 - --D 5 0001652724 Convertible Promissory Note
- -   Lucira Health, Inc. 3 - --D 4 0001652724 Series C Preferred Stock
- -   Lucira Health, Inc. 3 - --I 3 0001652724 Series C Preferred Stock
- -   Lucira Health, Inc. 3 - --I 2 0001652724 Series B Preferred Stock
- -   Lucira Health, Inc. 3 - --I 1 0001652724 Series A Preferred Stock
- -   Enovix Corp 3 - --I 17583258.0000 1 0001828318 Common Stock

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016